We are live on ! Find out more
SXL

Summit X LLC Portfolio holdings

AUM $536M
1-Year Est. Return 15.36%
This Fund
S&P 500
This Quarter Est. Return
-16.57%
1 Year Est. Return
+15.36%
3 Year Est. Return
+62.88%
5 Year Est. Return
+106.61%
10 Year Est. Return
AUM
$214M
AUM Growth
-$54.8M
Cap. Flow
-$2.14M
Cap. Flow %
-1%
Top 10 Hldgs %
31.93%
Holding
267
New
31
Increased
102
Reduced
54
Closed
68

Sector Composition

1 Technology 10.29%
2 Communication Services 7.83%
3 Financials 7.79%
4 Healthcare 6.6%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
176
CALL
Advanced Micro Devices
AMD
$798B
$98K 0.05%
33,900
+23,900
+239% +$1.15M
AAPL icon
177
CALL
Apple
AAPL
$4.88T
$58K 0.03%
80,800
+40,800
+102% +$3M
ISEE
178
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$52K 0.02%
15,000
-18,120
-55% -$106K
FSK icon
179
FS KKR Capital
FSK
$3.08B
$47K 0.02%
3,963
VSTM icon
180
Verastem
VSTM
$509M
$45K 0.02%
1,417
+584
+70% +$14.6K
AMZN icon
181
CALL
Amazon
AMZN
$2.68T
$40K 0.02%
+6,000
New +$581K
TRVN
182
DELISTED
Trevena, Inc.
TRVN
$38K 0.02%
107
+20
+23% +$9.57K
LYG icon
183
Lloyds Banking Group
LYG
$86.1B
$36K 0.02%
22,702
+3,190
+16% +$8.22K
EYPT icon
184
EyePoint Inc
EYPT
$1.13B
$26K 0.01%
2,550
+1,350
+113% +$20K
LCTX icon
185
Lineage Cell Therapeutics
LCTX
$302M
$25K 0.01%
30,700
+9,500
+45% +$9.46K
BA icon
186
CALL
Boeing
BA
$170B
$19K 0.01%
+1,400
New +$383K
SNGX icon
187
Soligenix
SNGX
$5.23M
$19K 0.01%
48
-4
-8% -$2.27K
NMTR
188
DELISTED
9 Meters Biopharma
NMTR
$19K 0.01%
1,700
+50
+3% +$627
PTN
189
Palatin Technologies
PTN
$14.8M
$15K 0.01%
28
+2
+8% +$1.47K
XXII
190
22nd Century Group
XXII
$1.43M
0
ATNM icon
191
Actinium Pharmaceuticals
ATNM
$28.3M
$10K ﹤0.01%
1,750
+167
+11% +$1.19K
UWT
192
DELISTED
VelocityShares3x Long Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER
UWT
$9K ﹤0.01%
+56,309
New +$395K
QRVO icon
193
CALL
Qorvo
QRVO
$7.4B
$7K ﹤0.01%
+8,000
New +$800K
DNN icon
194
Denison Mines
DNN
$2.54B
$3K ﹤0.01%
11,000
GERN icon
195
CALL
Geron
GERN
$943M
$2K ﹤0.01%
27,100
+900
+3% +$1.1K
NSLR
196
CALL
Neostellar Capital Corp
NSLR
$275M
$2K ﹤0.01%
+11,913
New +$61.6K
ACB
197
CALL
Aurora Cannabis
ACB
$162M
$1K ﹤0.01%
+208
New +$37.1K
NMTR
198
CALL
DELISTED
9 Meters Biopharma
NMTR
$1K ﹤0.01%
+500
New +$6.27K
ABT icon
199
Abbott
ABT
$177B
-2,373
Closed -$205K
ACB
200
Aurora Cannabis
ACB
$162M
$0 ﹤0.01%
+3
New +$536

Similar funds

Summit X LLC's Q1 2020 Portfolio in Review

As of Q1 2020, Summit X LLC held 267 positions worth $214M, down 20% from $269M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Summit X LLC's Q1 2020 filing shows 31 new, 102 increased, 54 reduced and 68 closed positions. Its largest new stake was iShares ESG Aware MSCI USA ETF: 69,792 shares worth $4.02M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $2.69M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8% a quarter earlier, followed by Communication Services and Financials.

  • Summit X LLC's largest Q1 2020 buy was iShares ESG Aware MSCI USA ETF: 69,792 shares worth $4.02M.
  • Summit X LLC added most to Apple in Q1 2020, an estimated $2.89M increase.
  • Summit X LLC's biggest Q1 2020 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $2.69M.
  • Summit X LLC fully exited Cisco in Q1 2020, selling an estimated $2.42M.
  • Summit X LLC's ten largest holdings make up 32% of its $214M portfolio in Q1 2020.
  • Summit X LLC opened 31 new positions and closed 68 in Q1 2020.
  • Summit X LLC's portfolio value fell 20% quarter-over-quarter to $214M.

Based on Summit X LLC's 13F filing for Q1 2020, filed 13 May 2020.